Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

Journal of Neural Transmission

Volumn 112, Issue 9, 2005, Pages 1237-1248

  Barcia, C ^a   Bautista, V ^a   Sanchez Bahillo A ^a   Fernandez Villalba E ^a   Faucheux, B ^b   Poza Y Poza, M ^a   Fernandez Barreiro, A ^a   Hirsch, E C ^b   Herrero, M T ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brain inflammation; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; TOXIC SUBSTANCE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BLOOD VESSEL; BRAIN BLOOD VESSEL; BRAIN REGION; CONTROLLED STUDY; DISEASE PREDISPOSITION; MALE; METHODOLOGY; MONKEY; NERVE CELL; NONHUMAN; NUTRIENT; PARKINSONISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEREOLOGY; SUBSTANTIA NIGRA; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MALE; NEURONS; PARKINSONIAN DISORDERS; RETICULIN; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24044459763     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-004-0256-2     Document Type: Article

References (52)

1. C Barcia V Bautista A Sanchez-Bahillo E Fernandez-Villalba JM Navarro-Ruis AF Barreiro Y Poza M Poza MT Herrero 2003 Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl- tetrahydropyridine-treated monkeys. Neuroendocrinology 78 118 128
2. C Barcia V De Pablos V Bautista-Hernandez A Sanchez-Bahillo A Fernandez-Barreiro M Poza MT Herrero 2004a Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity. J Neurosci Methods 134 59 64
3. C Barcia A Sanchez Bahillo E Fernandez-Villalba V Bautista M Poza y Poza A Fernandez-Barreiro EC Hirsch MT Herrero 2004b Evidence of active microglia insubstantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46 402 409
4. H Beck T Acker AW Puschel H Fujisawa P Carmeliet KH Plate 2002 Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J Neuropathol Exp Neurol 61 339 350
5. G Breier U Albrecht S Sterrer W Risau 1992 Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114 521 532
6. MW Brightman 1965 The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution. Am J Anat 117 193 219
7. P Carmerliet KJ Rakesh 2000 Angiogenesis in cancer and other diseases. Nature 407 249 257
8. D Casper SJ Engstrom GR Mirchandani A Pidel D Palencia PH Cho M Brownlee D Edelstein HJ Federoff WJ Sonstein 2002 Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer. Cell Transplant 11 331 349
9. JC Chavez F Agani P Pichiule JC LaManna 2000 Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol 89 1937 1942
10. C Emanueli P Schratzberger R Kirchmair P Madeddu 2003 Paracrine control of vascularization and neurogenesis by neurotrophins. Br J Pharmacol 140 614 619
11. EV Famiglietti EG Stopa ED McGookin P Song V LeBlanc BW Streeten 2003 Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina. Brain Res 969 195 204
12. BA Faucheux N Nillesse P Damier G Spik A Mouatt-Prigent A Pierce B Leveugle N Kubis JJ Hauw Y Agid EC Hirsch 1995 Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92 9603 9607
13. BA Faucheux AM Bonnet Y Agid EC Hirsch 1999 Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353 981 982
14. JM Fearnley AJ Lees 1991 Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 2283 2301
15. DL Felten KA Crutcher 1979 Neuronal-vascular relationships in the raphe nuclei, locus coeruleus, and substantia nigra in primates. Am J Anat 155 467 481
16. AM Graybiel CW Ragsdale Jr 1978 Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 75 5723 5726
17. MK Han M Kim SY Bae L Kang SY Han YS Lee JH Rha SU Kim JK Roh 2004 VEGF protects human cerebral hybrid neurons from in vitro ischemia. Neuroreport 15 847 850
18. A Hartmann S Hunot PP Michel MP Muriel S Vyas BA Faucheux A Mouatt-Prigent H Turmel A Srinivasan M Ruberg GI Evan Y Agid EC Hirsch 2000 Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97 2875 2880
19. T Hayashi K Abe H Suzuki Y Itoyama 1997 Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28 2039 2044
20. MT Herrero EC Hirsch A Kastner M Ruberg MR Luquin J Laguna F Javoy-Agid JA Obeso Y Agid 1993a Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56 499 511
21. MT Herrero EC Hirsch A Kastner MR Luquin F Javoy-Agid LM Gonzalo JA Obeso Y Agid 1993b Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem. Dev Neurosci 15 37 48
22. MT Herrero I Perez-Otaño C Oset A Kastner EC Hirsch Y Agid MR Luquin JA Obeso J Del Rio 1993c GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56 965 972
23. EC Hirsch 1992 Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 32 S88 S93
24. EC Hirsch BA Faucheux 1998 Iron metabolism and Parkinson's disease. Mov Disord 13 39 45
25. E Hirsch AM Graybiel YA Agid 1988 Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 345 348
26. S Hunot B Brugg D Ricard PP Michel MP Muriel M Ruberg BA Faucheux Y Agid EC Hirsch 1997 Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci USA 94 7531 7536
27. C Imbert E Bezard S Guitraud T Boraud CE Gross 2000 Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods 96 71 76
28. KL Jin XO Mao DA Greenberg 2000a Vascular endothelial growth factor: direct neuroprotective effect in vitro ischemia. Proc Natl Acad Sci USA 97 10242 10247
29. KL Jin XO Mao DA Greenberg 2000b Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci 14 197 203
30. K Jin XO Mao SP Batteur E McEachron A Leahy DA Greenberg 2001 Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 108 351 358
31. J Josko 2003 Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res 981 58 69
32. MY Lee WK Ju JH Cha BC Son MH Chun JK Kang CK Park 1999 Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci Lett 265 107 110
33. F Lennmyr KA Ata K Funa Y Olsson A Terent 1998 Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 57 874 882
34. MR Luquin J Laguna MT Herrero JA Obeso 1993 Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys. J Neurol Sci 114 40 44
35. H Matsuzaki M Tamatani A Yamaguchi K Namikawa H Kiyama MP Vitek N Mitsuda M Tohyama 2001 Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J 15 1218 1220
36. EG McGeer PL McGeer 1997 The role of the immune system in neurodegenerative disorders. Mov Disord 12 855 858
37. J Naoumenko I Feigin 1974 A simple silver solution for staining reticulin. Stain Technol 49 153 155
38. B Nico P Corsi A Vacca L Roncali D Ribatti 2002 Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain. Brain Res 953 12 16
39. OO Ogunshola A Antic MJ Donoghue SY Fan H Kim WB Stewart JA Madri LR Ment 2002 Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 277 11410 11415
40. Olzewski J, Baxter D (1954) Cytoarchitecture of the human brain stem. JB Lippincott, Philadelphia
41. HM Pinedo HM Verheul RJ D'Amato J Folkman 1998 Involvement of platelets in tumour angiogenesis? Lancet 352 1775 1777
42. TS Reese MJ Karnovsky 1967 Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34 207 217
43. W Risau 1997 Mechanisms of angiogenesis. Nature 386 671 674
44. R Seljelid S Jozefowski B Sveinbjornsson 1999 Tumor stroma. Anticancer Res 19 4809 4822
45. WF Silverman JM Krum N Mani JM Rosenstein 1999 Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 90 1529 1541
46. M Sondell M Kanje 2001 Postnatal expression of VEGF and its receptor flk-1 in peripheral ganglia. Neuroreport 12 105 108
47. M Sondell F Sundler M Kanje 2000 Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 12 4243 4254
48. DC Sterio 1984 The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134 127 136
49. J Stone A Itin T Alon J Pe'er H Gnessin T Chan-Ling E Keshet 1995 Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15 4738 4747
50. E Tischer R Mitchell T Hartman M Silva D Gospodarowicz JC Fiddes JA Abraham 1991 The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 11947 11954
51. GD Yancopoulos D Davis NW Gale JS Rudge SJ Wiegand J Holash 2000 Vascular-specific growth factors and blood vessels formation. Nature 407 242 248
52. T Yasuhara T Shingo K Kobayashi A Takeuchi A Yano K Muraoka T Matsui Y Miyoshi H Hamada I Date 2004 Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19 1494 1504